510(k) K962503
K962503 is an FDA 510(k) premarket notification submitted by Target Therapeutics for the device "GUGLIELMI DETACHABLE COIL". The FDA issued a decision of Substantially Equivalent on September 20, 1996. The device falls under product code HCG (Device, Neurovascular Embolization), a Class II device regulated under 21 CFR 882.5950. Target Therapeutics has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 20, 1996
- Date Received
- June 27, 1996
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Device, Neurovascular Embolization
- Device Class
- Class II
- Regulation Number
- 882.5950
- Review Panel
- NE
- Submission Type